Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Karan Omidvari"'
Autor:
Ronaldo C. Go, MD, Roshan Shah, MD, Themba Nyirenda, PHD, Yukiko Oe, MD, Khurram Sarfraz, MD, Justin J. Panthappattu, MD, Lesley Philip, MD, Chandni Bheeman, DO, Neel Shah, DO, Sapan Shah, MD, Sophia Dar, MD, Sung Hung, MD, Waqas Rahman, MD, Hyun Im, MD, Michael Marafelias, Karan Omidvari, MD, Anuja Pradhan, MD, Sean Sadikot, MD, Keith M. Rose, MD, Steven J. Sperber, MD, Joshua Josephs, MD
Publikováno v:
Critical Care Explorations, Vol 3, Iss 7, p e0493 (2021)
OBJECTIVES:. To determine methylprednisolone’s dose, duration, and administration from onset of symptoms and association with 60 days in hospital survival of coronavirus disease 2019 pneumonia. DESIGN:. Cohort study. SETTING:. Thirteen hospitals in
Externí odkaz:
https://doaj.org/article/a4c826ca356a4bd6960f15ac7699c4f6
Autor:
Sung Hung, Waqas Rahman, Khurram Sarfraz, Yukiko Oe, Joshua Josephs, Justin J. Panthappattu, Steven J. Sperber, Sean Sadikot, Sapan Shah, Ronaldo C. Go, Karan Omidvari, Hyun Im, Themba Nyirenda, Lesley Philip, Anuja Pradhan, Sophia Dar, Michael Marafelias, DO Chandni Bheeman, Roshan Shah, DO Neel Shah, Keith M. Rose
Publikováno v:
Critical Care Explorations
Crit Care Explor
Critical Care Explorations, Vol 3, Iss 7, p e0493 (2021)
Crit Care Explor
Critical Care Explorations, Vol 3, Iss 7, p e0493 (2021)
Supplemental Digital Content is available in the text.
OBJECTIVES: To determine methylprednisolone’s dose, duration, and administration from onset of symptoms and association with 60 days in hospital survival of coronavirus disease 2019 pneumo
OBJECTIVES: To determine methylprednisolone’s dose, duration, and administration from onset of symptoms and association with 60 days in hospital survival of coronavirus disease 2019 pneumo
Publikováno v:
Chest. 160:A826-A827
Publikováno v:
Chest
TOPIC: Chest Infections TYPE: Medical Student/Resident Case Reports INTRODUCTION: SARS-CoV-19 pandemic is a global health emergency and burden. Millions of people worldwide have been affected and cases continue to rise. Health organizations have focu
Publikováno v:
Chest
Does Surgical Repair of Moderate Ischemic Mitral Regurgitation Improve Survival? A Systematic Review
Autor:
Hafeez Ul Hassan Virk, Chirag Bavishi, Karan Omidvari, Mohammed Ahmed, Jay Giri, Joanna Chikwe, Partha Sardar, Byomesh Tripathi, Parasuram Krishnamoorthy, Saurav Chatterjee
Publikováno v:
Current cardiology reports. 18(3)
Mitral regurgitation (MR) is one of the common complications in myocardial infarction (MI) patients. Almost half of the post MI patients have MR (ischemic MR)(17) which is moderate to severe (grade II-IV). Whether there is a mortality benefit of perf
Publikováno v:
Clinical Pulmonary Medicine. 5:182-190
Publikováno v:
Alcoholism: Clinical and Experimental Research. 22:567-572
Alcohol is an immunosuppressive drug, and chronic abuse has been associated with increased susceptibility to a variety of infections, including bacterial pneumonia and tuberculosis. Alveolar macrophages are the resident phagocytes of the lung and pla
Publikováno v:
Clinical Pulmonary Medicine. 3:36-42
Publikováno v:
Journal of the American College of Cardiology. 67:2054